Several innovative medications are revolutionizing diabetes treatment, with Retatrutide, Cagrillintide, Tirzepatide, and Semaglutide standing out promising choices. Retatrutide, a dual GIP and GLP-1 receptor activator, exhibits remarkable fat reduction coupled with improved glycemic control. Cagr